HR+, HER2- Early Breast Cancer: Patient Case
Overview
Welcome to the BreastRisk-Sim early breast cancer (EBC) patient case simulation. This simulation guides you through a hormone receptor–positive (HR+), human epidermal growth factor receptor 2–negative (HER2-) EBC patient case. Through this hypothetical patient case, you will understand how to assess the risk of disease recurrence in patients with HR+, HER2- EBC, as well as identify patients with clinicopathological high-risk HR+, HER2- EBC.
VV-MED-173653
Please rate your satisfaction with the content on the following statements:
Very Dissatisfied
Dissatisfied
Neutral
Satisfied
Very Satisfied
Credibility of information
Relevance of the information to my needs
Confidence to implement the learnings in my clinical practice
Please rate your satisfaction with the content on the following statements:
Credibility of information
Relevance of the information to my needs
Confidence to implement the learnings in my clinical practice